Intellipharmaceutics International Inc. (IPCI)

[fabius]

Recent Market action I think just reflects the usual strategy for small biotech; short each time there is a spike up and remaining cash for the company is drying up.

FDA decision to require new bioequivalence just materialized the idea that IPCI will need cash in near term and therefore will issue new shares (I'm not telling that is what will happen).

Now, if FDA keeps on stalling on other pending approval the price will deteriorate because shorts will increase their convinction about future diluition.

Even if we think this stock is cheap, will soar, it's a bargain....we just depend on FDA burocracy...and nobody can assure us that future delays/complications will shift approvals even further.

I recently added more shares, but I've seen lot of times small cap stocks being hammered on low volumes.

And what is disturbing me is that a minor news on new bioequivalence requirements had a much bigger impact on the price than those Amazing regarding Rexista and Prodras..